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Abstract: Developing effective and safe drugs is imperative for replacing antibiotics and 
controlling multidrug-resistant microbes. Nanoscale silicate platelet (NSP) and its nanohybrid, 
silver nanoparticle/NSP (AgNP/NSP), have been developed, and the nanohybrids show a strong 
and general antibacterial activity in vitro. Here, their efficacy for protecting Salmonella-infected 
chicks from fatality and septicemia was evaluated. Both orally administrated NSP and AgNP/
NSP, but not AgNPs alone, effectively reduced the systemic Salmonella infection and mortality. 
In addition, quantitative Ag analyses demonstrated that Ag deposition from AgNP/NSP in the 
intestines was less than that from conventional AgNPs, indicating that the presence of NSP for 
immobilizing AgNPs reduced Ag accumulation in tissue and improved the safety of AgNPs. 
These in vivo results illustrated that both NSP and AgNP/NSP nanohybrid represent potential 
agents for controlling enteric bacterial infections.
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Introduction
Both soluble silver (Ag) ion species and colloidal silver nanoparticles (AgNPs) are 
well documented as effective antiseptics for controlling broad-spectrum microbes 
and antibiotic-resistant bacteria in vitro.1–4 Recently, some discoveries have also 
shown that AgNPs are superior to conventional Ag ions for inhibiting bacterial 
growth.5,6 Ag is extensively used in many commercial products, including medi-
cal devices, because of its relatively low toxicity. The guideline for maximal Ag 
dose in drinking water for humans by the US Environmental Protection Agency 
is 100 ppb. In addition, additives containing AgNPs have been considered in 
domestic animal diets.7 However, the efficacy of AgNPs or their derivatives for 
controlling microbial infections in the digestive tract of animals has not yet been   
reported.
In considering the relative toxicity of AgNPs and Ag ions in medicine, the former 
has been shown to be approximately three times less toxic than the latter in a human 
monocytic cell line and in zebrafish.8,9 Compared with Ag sulfadiazine, topical appli-
cation of an AgNP complex on mouse skin showed significantly reduced Ag deposi-
tion in the blood, feces, and internal organs, demonstrating the lower percutaneous 
adsorption rate for AgNPs than for Ag ions.10
In spite of these advantages for AgNPs as a new antiseptic, metal nanoparticles 
have an inherent tendency for aggregation. The reduction in these nanoparticles’ reac-
tive surfaces affects the efficacy for controlling pathogens in solution.11 In addition, 
for clinical application of AgNPs, especially for controlling internal organ infections, 
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the cytotoxicity and the accumulation of Ag deposition in 
tissues are still the major safety concerns.12
The approach of using a high-aspect-ratio nanoscale silicate 
platelet (NSP) clay for supporting AgNPs has been taken.6 The 
NSP was fabricated by exfoliating the natural clay of sodium 
montmorillonite (Na+-MMT).13,14 The purified NSPs were nega-
tively charged and existed in irregular polygonal shapes with 
extremely thin dimensions of 80 × 80 × 1 to 100 × 100 × 1 nm3 
(1.0 nm thickness). The developed process yielded NSPs as 
randomized clay platelets with large surface areas (ca 750 m2/g) 
and strong ionic charges (ca 12,000–19,000 charges/platelet).14 
These features enabled NSPs to attract metal ions, polar organic 
molecules, and microbial cell surfaces effectively.6,15,16 For 
instance, the use of NSP provides an extensive reactive surface 
for adhering spherical AgNPs fabricated by the in situ reduc-
tion of Ag ions with a reducing agent.6 Acting as a dispersant 
and a carrier, NSP immobilizes and concentrates AgNPs on 
an ultrathin platelet.
The strong attraction of NSP to microbes was demon-
strated by treating NSP and its AgNP/NSP nanohybrid with 
Salmonella, which aggregated the bacterial cells into a small 
cluster.6 This bridging effect of the NSP was speculated to be 
caused by the extensive reactive surface of the nanomaterial. 
Examining the bacteria-NSP complex under a transmis-
sion electronic microscope revealed that the NSP primarily 
enwrapped the bacterial cell instead of penetrating into the 
cell.6,15,17,18 The AgNP/NSP nanohybrids were demonstrated 
to be an effective antibacterial agent mainly through the 
robust production of reactive oxygen species on the contacted 
bacterial membrane.6,18
Experimental results suggested that the NSP carriers might 
impede the accumulation of AgNPs when topically applied to 
cells and tissues. In addition, the unique characteristics of NSP 
may make the nanohybrid a potential drug to control bacte-
rial infections in the body, such as in the gastrointestinal (GI) 
tract, with an attenuated detrimental effect of Ag   deposition. 
To test this hypothesis, NSP, AgNP/NSP, and AgNPs 
were orally administrated to Salmonella-infected chicks. 
The   nanoparticles’ antibacterial efficacy was subsequently 
examined. In addition, the comparative safety of the fed Ag 
nanomaterials, including the cytotoxicity, Ag adsorption, and 
organ distribution in internal organs, was also evaluated.
Materials and methods
Preparation of NSP, AgNP/NSP,  
and AgNPs
NSPs were prepared from a Na+-form layered smectite 
clay, montmorillonite (Na+-MMT; Nanocor Inc, Hoffman 
Estates, IL), according to the reported exfoliation process.14 
The procedures for preparing the AgNP/NSP nanohybrid 
have been described in detail previously.14 The formation 
of AgNPs was monitored by observing the color change 
and ultraviolet absorption at 414 nm. The particle sizes 
were measured by field emission scanning electronic 
microscopy (FE-SEM; Zeiss EM 902A) at 80 kV . The size 
distribution was estimated from 100 individual particles. The 
concentration of AgNP on NSP was determined by an atomic 
absorption spectrometer (iCE 3300; Thermo Scientific, 
Waltham, MA).
The synthetic procedure for poly(styrene-co-maleic 
anhydrides) (SMA) has been described in a recent report.19 
The SMA-AgNPs were prepared chemically by reducing Ag 
salts into NPs by NaBH4.16 The excess Ag ions and free SMA 
were further removed by dialysis.16 The particle sizes were 
estimated by transmission electronic microscope (200EX, 
JEOL, Tokyo, Japan) at 80 kV . The chemical composition 
was 17.5% Ag and 82.4% SMA, as determined by thermo-
gravimetric analysis (PerkinElmer TGA7, Waltham, MA).
Determination of zeta potential
NSP, AgNP/NSP, and SMA-AgNPs were all dissolved 
and diluted in water. The zeta potential was measured five 
times by Laser Doppler Electrophoresis (Zetasizer Nano 
ZS, Malvern, UK) at 25°C ± 0.1°C and calculated using the 
Smoluchowski approximation.
Bacterial organisms
Two Salmonella enteric field isolates, serovar pullorum and 
typhimurium (S. pullorum and S. typhimurium), were pro-
vided by Dr Jun-Hong Lin at the Animal Technology Institute 
Taiwan. Specific pathogen-free (SPF) white Leghorn chicks 
were purchased from the Animal Health Research Institute in 
Taiwan. The animal use protocol was reviewed and approved 
by the Institutional Animal Care and Use Committee at the 
National Chung Hsing University (NCHU, No 99-42).
Infection of Salmonella in chicks
The challenge procedure of Salmonella in SPF chicks was 
modified from the report described by Roy et al.20 Fresh 
S. pullorum were prepared in Luria-Bertani (LB) broth (OD600 
0.4–0.6) (Difco Laboratories, Detroit, MI) and concentrated 
to make the stock at 5 × 1010 colony-forming units (CFU)/mL. 
One-day-old Leghorn chicks were fed with 0.1 mL bacterial 
stock six times within 3 days. During the period of challenges, 
the animals remained starved to help the colonization of 
Salmonella in the GI tract.
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Detection of S. pullorum in blood
The blood was harvested from the heart of the sacrificed 
animal on day 5 under a sterilized operation. The S  almonella 
in the blood were amplified in buffered peptone water 
(  Acumedia, Neogen Corporation, Lansing, MI) for 18 hours 
at 37°C, and a 50 µL aliquot was further streaked on blood 
agar for overnight culture. Single colonies were picked 
and grown in LB broth overnight. Finally, the amplified 
  Salmonella were distinguished by the transparency of the 
colonies on MacConkey selective agar (Acumedia).
Detection of S. typhimurium in tissues
The isolation of S. typhimurium in tissues followed the 
reported method.21 Briefly, tissues (100–200 mg) from inter-
nal organs were homogenized, and the supernatants (100 µL) 
were aseptically inoculated into 5 mL buffered peptone 
water and grown overnight. Aliquots were further grown 
in Rappaport–Vassiliades broth (Acumedia) for enrich-
ment and incubated at 37°C for 24 hours. A loop full of the 
Rappaport–Vassiliades broth was spread on to MacConkey 
agar and Salmonella–Shigella selective agar (Acumedia). 
Typical colonies of Salmonella showed transparency of 
colonies with black centers on the Salmonella–Shigella agar 
after overnight culture.
MTT viability assay
The LoVo and C2BBel cells, which were obtained from 
the Bioresource Collection and Research Center (BCRC) 
in Taiwan, were split into 24-well culture plates at a den-
sity of 5 × 104 cells/well in 1 mL culture medium and 
allowed to attach for 24 hours before treatment. After the 
medium was added with AgNP/NSP, the cells were incu-
bated at 37°C under 5% CO2 for 24 hours. The cells were 
stained with methylthiazolyldiphenyl tetrazolium bromide 
(MTT)   solution (500 µg/mL) at 37°C for 2 hours. After the 
removal of the supernatant, dimethyl sulfoxide was applied 
to dissolve the formazan crystals. The optical density was 
obtained on an ELISA reader at 595 nm (DV-990-BV , GDV , 
Rome, Italy).
Pathological and ICP-MS examinations
One-day-old SPF chicks (approximately 40 g) were fed 
NSP, AgNP/NSP, or AgNPs once with 200 µL tips. Before 
tissue collection, 1-week-old chicks fasted overnight and 
were subsequently anesthetized and sacrificed with CO2. 
Tissue samples (approximately 250 mg) from the gizzard 
(middle part), small intestine (middle part), large intestine 
(middle part), liver (median lobe), lungs (median lobe), 
kidney (whole), and heart (whole) were collected for later 
histopathological examination. The pathological report was 
issued by Animal Disease Diagnostic Center in NCHU.
The tissue samples subjected to inductively coupled 
plasma-mass spectrometry (ICP-MS) analysis were washed 
three times with phosphate buffered saline to remove any 
adherent nanomaterials. All oven-dried samples were 
digested with 65% nitric acid at 180°C for 30 minutes in 
a microwave oven (MARS-Xpress, CEM Corporation, 
Matthews, NC). The Ag concentration of the nanomaterial 
suspensions was determined using an ICP-MS (ELAN 6100 
DRC, PE-SCIEX) in the Soil Survey and Testing Center at 
NCHU. The limit of detection was estimated at 0.7–2.0 ppb 
in the examined samples.
Statistical analysis
Each experiment was performed in duplicate or triplicate, 
and the derived data were presented as the mean ± standard 
deviation. Statistical analysis of the data was conducted 
using SPSS software (SPSS, Inc, Chicago, IL). Significance 
of differences was analyzed with one-way or two-way 
analysis of variance (ANOVA) and Tukey’s post-hoc test 
using SPSS software. The statistical significance was set at 
P-value , 0.05.
To calculate the 50% lethal dose (LD50) of the tested nano-
materials in cultured cells, MTT data from three independent 
experiments were collected and fitted to a power curve trend 
and a four-parameter nonlinear logistic model. The LD50 
values were estimated using a fit model (power series 550) 
and a predicted X model in XLfit 5.3 software (ID Business 
Solutions, Surrey, UK) (http://www.excelcurvefitting.com/
index.html).
Results
Characterization of the NSP, AgNP/NSP, 
and AgNPs
The method for fabrication of NSP and AgNP/NSP is briefly 
illustrated in Figure 1A and B.6,13,14,22 The AgNP/NSP was 
synthesized by the reduction of Ag nitrate in the presence 
of NSP. The morphology of NSP was examined under SEM 
(Figure 1E and F), showing an irregular polygonal shape 
with approximately 100 × 100 nm2 dimensions. Regarding 
the AgNP/NSP nanohybrid, the synthesized AgNPs were 
free of polymers and well dispersed on the NSP platelet. 
The spherical particle diameter was 7 ± 3 nm (Figure 1F), 
and the weight ratio of AgNPs to NSP was 1:11.5. The Ag 
content of 1.0 wt% AgNP/NSP was 650 ppm. The ICP-MS 
analysis showed that the dissolved Ag ion concentration of 
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1.0 wt% AgNP/NSP was 509 ppb, indicating that the applied 
Ag nitrate was almost completely reduced and less than 0.1% 
total Ag (0.509 ppm/650 ppm) was dissociated.
The zeta potential of 0.1 wt% NSP was −44.0 ± 1.2 mV and 
that of 0.1 wt% AgNP/NSP nanohybrid was −38.9 ± 0.3 mV . 
These results demonstrated that the immobilized AgNPs did 
not dramatically alter the electrical potential of the original 
NSP. The electrostatic stabilization of metal particles in 
solution generally requires a zeta potential above 30 mV or 
below −30 mV .23 The low Ag dissociation rate and the low 
zeta potential of AgNP/NSP both suggested that the AgNPs 
on the NSP carrier were stable in a reduced form and were 
well dispersed in water.
To generate size- and homogeneity-controlled AgNPs, 
the copolymer SMA was used as a steric stabilizer for 
AgNPs.16 SMA has already been applied for coating 
anticancer drugs to reduce drug release and toxicity in 
vivo.24,25 In addition, the SMA will probably not affect 
antibacterial tests due to its high biocompatibility and 
weak bactericidal effect.16,26 The SMA-AgNPs, designated 
AgNPs in the following text and graphs, were prepared 
chemically by reducing Ag nitrate with NaBH4 into 
NPs (Figure 1C). The particle size was estimated to be 
8.6 ± 0.2 nm (Figure 1G), similar to the AgNP size of 
AgNP/NSP. The concentration of the SMA-coated AgNPs 
was determined by thermogravimetric analysis, and the 
weight ratio of AgNP to SMA was found to be 1:4.7. The 
Ag content in the stock AgNPs solution (0.37 wt%, 650 
ppm Ag) was similar to that in the 1.0 wt% AgNP/NSP 
solution. After centrifuging the AgNPs at 140,000 × g for 
20 hours at 20°C, the AgNPs solution appeared to be light 
brown in comparison with the clear supernatants of NSP 
and AgNP/NSP (Figure 1D). The supernatants of these 
nanomaterials were assumed to contain few AgNPs because 
this ultracentrifugation precipitates particles above 1 nm in 
diameter.27 ICP-MS revealed that the Ag ion concentration 
in the stock AgNPs solution was 30.0 ppm. To reduce the 
interference of Ag ions in the following tests, the fabricated 
AgNPs were dialyzed and ultracentrifuged before use. The 
supernatant of dialyzed SMA-AgNP was clear and showed 
no antibacterial activity in vitro. The resuspended AgNPs 
were well dispersed in water with a −32.1 ± 0.3 mV zeta 
potential.
Controlling Salmonella infection  
with NSP and AgNP/NSP
Salmonellosis is a severe threat to the poultry industry and 
public health. Eliminating Salmonella infection in chickens 
will reduce the bacterial pollution in meat and the infection 
risk to humans. In this study, newborn SPF chicks were used 
as the animal model for bacterial GI infection. No viable 
Salmonella were ever isolated from the recruited SPF chicks. 
The animals were starved for 3 days to help the colonization 
of exogenous Salmonella in the GI tract during the oral chal-
lenges (Figure 2A). Feeding of Salmonella enteric serovar 
pullorum (S. pullorum) (5 × 109 CFU), a lethal pathogen 
specifically for chicks,20 resulted in 30% mortality on day 
10 after two or four oral challenges within the three fasting 
days (square and triangle, respectively, in Figure 2B). When 
the chicks were challenged six times during the 3-day fast-
ing period, 90% mortality was achieved (dots in Figure 2B). 
This six-time challenge schedule was therefore applied in the 
following experiments.
Interestingly, feeding 10 mg/kg NSP (0.4 mg NSP to 
a 40 g chick) or 10 mg/kg AgNP/NSP once at postnatal 
30 hours (6 hours after the second challenge) successfully 
A  NSP E  NSP
F  AgNP/NSP
G  AgNPs
B  AgNP/NSP
C  AgNPs
D
NSP + AgNO3
Poly(styrene-co-maleic anhydride)
 + AgNO3
NaBH4
Methanol 80°C
100 nm
NSP AgNPs AgNP/NSP NSP
Centrifugation
AgNP/NSP AgNPs
50 nm
20 nm
O
Si
Al
H
Figure  1  The  characteristics  of  the  nanoscale  silicate  platelet  (NSP),  silver 
nanoparticle  (AgNP)/NSP,  and  AgNPs.  (A–C)  The  molecular  structure  of  NSP 
produced by ChemDraw is illustrated (A). The shapes and fabrication procedures 
of NSP (A), AgNP/NSP (B), and AgNPs (C) are illustrated. (D) The synthesized 
nanomaterials were precipitated by the centrifugation at 140,000 × g for 20 hours 
at 20°C. (E–G) Scanning electronic microscopy pictures of the NSP (E), AgNP/NSP, 
(F) and AgNPs (G) are presented.
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improved the chicks’ mortality on day 10 from 6.7% ± 5.8% 
to 50.0% ± 17.3% (P , 0.05, two-way ANOVA test) or 
to 73.3% ± 5.8% (P , 0.01), respectively (Figure 2C). 
According to these results, the 50% effective dose (ED50) 
of NSP and AgNP/NSP for controlling Salmonella was 
approximately 10 mg/kg or less. Although 3-day starva-
tion weakened the chicks during the bacterial challenges, 
most infected chicks were alive on day 3, and over 90% 
of the uninfected chicks survived to day 10. The endpoint 
of examination was on day 10 because the mortality of the 
chicks was generally not altered past this age.
Controlling Salmonella infection  
with AgNPs
We next examined the bactericidal activity of AgNPs on 
Salmonella in vitro and in vivo. The AgNPs effectively 
inhibited the growth of S. pullorum and Escherichia coli on 
agars and showed a similar potency to that of AgNP/NSP 
(Supplementary data Figure S1).16 The chicks were thus fed 
with 3.75 mg/kg (the same Ag content as the AgNP/NSP 
group in Figure 2C) and 37.5 mg/kg AgNPs following the 
schedule illustrated in Figure 2A. Surprisingly, mortality 
rates of both the 3.75 mg/kg and 37.5 mg/kg AgNP-treated 
chicks were 90% on day 10, indicating the incompetence on 
protecting the Salmonella infection. Even when a ten-fold 
dose of Ag was administered, the AgNPs did not exhibit 
a comparable effect with NSP or AgNP/NSP on clearing 
enteric Salmonella (Figure 2D).
The environment of the GI tract of chicks, such as the 
low pH gastric juice, may reduce antibacterial potency of 
AgNPs in vivo. To investigate this possibility, both AgNP/
NSP and AgNPs were treated with a simulated gastric 
juice at 37°C, which contained 3 mg/mL pepsin in a HCl 
adjusted saline (pH 3.0, 0.85% NaCl).28 Interestingly, at 
30-minute treatment with gastric acid, the dark-brown 
AgNPs turned to gray, agglomerated, and precipitated (arrow 
in Figure 3A). In contrast, no gross change was observed 
for the acid-treated AgNP/NSP (Figure 3A). Examining the 
anti-Salmonella activity of the nanomaterials in LB broth 
further revealed that the gastric acid significantly reduced 
the biocidal effect of AgNPs (AgNP-A vs AgNP; P , 0.01 
at 8 hours and 12 hours post-treatment; one-way ANOVA) 
but not that of AgNP/NSP (Figure 3B). This experiment 
suggested that AgNP/NSP was gastroresistant, and the 
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Figure 2 Controlling Salmonella infection with the investigated nanomaterials. (A) Experimental conditions in newborn chicks, including the feeding schedules of both 
Salmonella pullorum (SP) and the nanomaterials. (B) The chicks were orally challenged with Salmonella twice (within day 1, square), four times (within the first 2 days, 
triangle), or six times (dot). (C and D) The chicks were challenged with Salmonella pullorum six times within the first 3 days. The nanoscale silicate platelets (NSPs) (C), silver 
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Note: The data represent three independent experiments (n = 10 per group) and were analyzed by two-way analysis of variance.
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stability of nanomaterials in gastric acid is a critical factor 
for antibacterial potency.
Preventing septicemia with NSP  
and AgNP/NSP
The occurrence of septicemia, caused by the spread of 
enteric Salmonella into the blood, primarily results in 
the fatality of infected newborn chicks.20 In addition 
to reduced mortality, AgNP/NSP also significantly 
prevented septicemia in the infected chicks (Figure 4A). To 
address this issue further, S. enteric serovar typhimurium 
(S. typhimurium) was also tested in this study. In contrast 
to the limited host of S. pullorum, S. typhimurium is a 
broad-spectrum zoonosis. In addition, S. typhimurium 
is featured with resistance to phagocytosis and causes 
systemic septicemia in infected animals.29
One-day-old chicks were orally challenged with 
S. typhimurium once (106 CFU) and sacrificed at 24 hours 
postinfection. As expected, the Salmonella were consistently 
isolated from enteric organs, including the gizzard (100%), 
the small intestine (95%), and the colon (95%) (Figure 4B). 
For the liver, lung, and spleen, the isolation rates were 70%, 
80%, and 50%, respectively (Figure 4C). Feeding 10 mg/kg 
NSP at 6 hours postinfection did not dramatically affect the 
isolation rate in enteric organs (Figure 4B) but inhibited the 
Salmonella spreading to the nonenteric organs (P , 0.05, one-
way ANOVA) (Figure 4C). Notably, treating 10 mg/kg AgNP/
NSP reduced the isolation rate of Salmonella from both the 
enteric and nonenteric organs (P , 0.05, one-way ANOVA) 
(Figure 4B and C). These results demonstrated that AgNP/NSP 
was effective in controlling Salmonella infection by preventing 
the transmission of enteric bacteria into the blood.
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Additional effect of the nanomaterials 
with antibiotics
The increasing dosages of antibiotics required for effective-
ness have motivated scientists to develop new strategies for 
controlling bacterial infections. With regard to this, 40 mg/kg 
amoxicillin once per day for three consecutive days was 
found to rescue the survival rate of S. pullorum-infected 
chicks from 15% to 75% (Figure 5). One-tenth of a usual 
amoxicillin dose (4 mg/kg) over three consecutive days pro-
vided 50% protection. Interestingly, adding NSP or AgNP/
NSP with 4 mg/kg amoxicillin increased the survival rate 
from 50% to 70% or 85% (P , 0.05) on day 10, respectively 
(Figure 5). This result suggested that both nanomaterials 
have an additive antibacterial effect with antibiotics for 
Salmonella prevention.
The cytotoxicity of AgNP/NSP
The cytotoxicity of NSP, AgNPs, and AgNP/NSP was tested 
in two common human intestinal epithelial cell lines, LoVo 
and C2BBel (a subclone of Caco-2) cells (Figure 6). In our 
previous study,13 treating Chinese hamster ovary cells with 
500 µg/mL and 1000 µg/mL NSP for 24 hours resulted in 
80% and 60% cell survival, respectively. Here, the study 
in LoVo cells revealed that 1000 µg/mL and 2000 µg/mL 
NSP gave 81.1% ± 1.2% and 57.6% ± 12.2% cell survival 
examined by the MTT assay (Figure 6A). The 50% lethal 
concentration (LC50) of NSP at 24 hours for LoVo cells was 
more than 2000 µg/mL, emphasizing the low toxicity of NSP 
to intestinal cells in vitro. This low toxicity of NSP was also 
recapitulated in a study with C2BBel cells (Figure 6C).
Compared  with  NSP,  AgNP/NSP  and  AgNPs 
showed higher cytotoxicity to human colon cancer cells 
(Figure 6B and D). The LC50 of AgNP/NSP and AgNPs 
at 24 hours post-treatment was 341 µg/mL (22.1 ppm Ag) 
and 205 µg/mL (36.1 ppm Ag) in LoVo cells, respectively 
(  Figure 6B). In addition, the LC50 of AgNP/NSP and AgNPs 
in C2BBel cells were 820 µg/mL (Ag, 53.3 ppm) and 
318 µg/mL (Ag, 55.8 ppm), respectively (Figure 6D). The 
averaged LC50 doses of AgNP/NSP and AgNPs for intesti-
nal cells were 37.7 ppm Ag and 46.0 ppm Ag, respectively. 
  Notably, cytotoxicity assays in human HT29 colon cells 
showed that the LC50 of pure AgNPs (particle size, 10–15 nm) 
was 27 ppm at 12 hours post-treatment.30 These results sug-
gested that AgNP/NSP and SMA-AgNPs were less cytotoxic 
than pure AgNPs on cultured intestinal cells.
The acute toxicity of the AgNP/NSP  
in vivo
To evaluate the safety of AgNP/NSP in vivo, a 50-fold 
higher dose of the nanohybrids (500 mg/kg), compared with 
that used in the aforementioned studies, was given to the 
1-day-old chicks. We found that during the first week, all 
examined chicks were healthy (Figure 7A) and showed no 
gross abnormality with respect to their appearance, appetite, 
and body weight (P . 0.05) (Figure 7B). The appearance of 
dark-brown feces from the chicks at 6 hours post-treatment 
of AgNP/NSP was observed, suggesting that fecal excretion 
was the primary excretion route for the orally applied nano-
material. We observed that the feces returned to a normal 
gray color on day 3 post-treatment.
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in culture medium. The cytotoxicity was estimated by the methylthiazolyldiphenyl tetrazolium bromide assay in triplicate.
Feeding AgNPs (187.5 mg/kg), NSP (500 mg/kg), and 
AgNP/NSP (500 mg/kg) to 1-day-old chicks did not cause 
notable gross tissue damage in the examined internal organs. 
Histological examinations by experienced pathologists 
revealed that the epithelial cells of the GI tract were intact, 
and inflammatory cells were not detected in the collected 
tissues of the nanomaterial-treated chicks, including GI 
tract, heart, lung, liver, and kidney (Table S1). These experi-
ments suggested that NSP and the AgNP/NSP nanohybrid 
were pharmacologically safe nanomaterials (therapeutic 
index, LD50/ED50 . 50) for controlling enteric bacterial 
infections.
In addition to histological examinations, tracing the 
nanosilver in the body is essential for evaluating the metabo-
lism of the nanohybrids and their long-term safety. The 
NSP (500 mg/kg), AgNP/NSP (500 mg/kg), and AgNPs 
(187.5 mg/kg; same Ag content to AgNP/NSP) were fed 
to 1-day-old chicks, and the Ag distribution of nanomateri-
als in their organs was determined by ICP-MS. In the NSP 
control group, the detected Ag concentrations were all 
lower than 30 ppb in the wet tissues of NSP-treated chicks 
(Figure 7C and D). For AgNP/NSP, the average Ag deposits 
in the GI tract were below 100 ppb. Importantly, feeding 
AgNPs resulted in 231 ± 83 ppb Ag and 285 ± 41 ppb 
Ag ions in the small and large intestine, respectively. The 
accumulated Ag in AgNPs-dosed intestines showed sig-
nificantly higher levels than those in the AgNP/NSP-treated 
group (P , 0.05, one-way ANOVA) (Figure 7C).
In the non-GI internal organs of AgNP/NSP- and AgNPs-
treated chicks, the Ag concentrations in heart tissue were below 
30 ppb (Figure 7D). We detected 61 ± 19 ppb and 82 ± 28 ppb 
in the lungs of AgNP/NSP and AgNPs groups, respectively. In 
the liver and kidney of AgNPs-treated chicks, 396 ± 95 ppb Ag 
and 378 ± 102 ppb Ag were found. Unexpectedly, 319 ± 80 ppb 
Ag and 315 ± 37 ppb Ag were detected in the liver and kidney 
of AgNP/NSP-treated chicks, respectively. These Ag concen-
trations in AgNP/NSP-dosed liver and kidney still exhibited 
a moderate, but not significant, reduction compared with the 
AgNP-treated group (P . 0.05) (Figure 7D).
Discussion
AgNPs have been proposed to be a potential drug for bacterial 
infection based on the strong bactericidal activity of AgNP 
in vitro. However, our study indicated that feeding AgNPs 
did not effectively rescue Salmonella-mediated mortality 
of the chicks. We further demonstrated that the AgNPs 
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coated with SMA copolymer were acid-instable, and the 
NPs became agglomerated in the presence of gastric acid. 
This study emphasized that the stability and dispersion of 
nanomaterials in vivo are key factors for their antibacterial 
potency in GI infections.
In contrast, the NSP clay, showing barely antibacterial 
effects in protein-rich medium,6 protected 50% Salmonella-
infected chicks from fatality. We speculate that the high 
cationic exchange capacity and the excellent dispersion 
enabled the NSP to be a potent adsorbent for enteric bacterial 
pathogens.14 NSP may encapsulate the bacteria and prevent 
the colonization of Salmonella on to the luminal epithelium of 
digestive tissues.6 Therefore, feeding NSP to chicks may not 
kill the colonized Salmonella but reduces bacterial mobility 
and brings the Salmonella or their released toxins away from 
the lumen of the intestines.
AgNP/NSP have been shown to be impressive antibacte-
rials in vitro, including for Salmonella and Ag ion-resistant 
E. coli.6,18 Here, in vivo studies further emphasized that 
AgNP/NSP effectively controlled enteric Salmonella infec-
tion and prevented septicemia in infected chicks. Combined 
with AgNP/NSP, only one-tenth the normal dose of amoxi-
cillin was required to achieve 80%–90% protection from 
Salmonellosis. The reduced dosage of applied antibiotics 
will reduce the risk of the emergence of antibiotic-resistant 
bacteria in field. These data further suggested that the AgNP/
NSP nanohybrid is a potential antimicrobial agent to treat 
infectious gastroenteritis in animals and humans.
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Figure 7 The acute toxicity of the nanomaterials in vivo. The newborn chicks (n = 10 per group) were fed once with 500 mg/kg nanoscale silicate platelet (NSP), 500 mg/kg 
silver nanoparticle (AgNP)/NSP, or 187.5 mg/kg AgNPs at postnatal 12 hours. The silver nanomaterials were given at the same silver content. (A) The surviving animals were 
recorded, and the chicks were weighed every day until day 7. (B) The weight data on day 7 are shown. (C and D) The organs of 1-week-old chicks (n = 3) were collected 
and oven-dried, and their silver deposits were determined by inductively coupled plasma-mass spectrometry.
Notes: The values indicate the silver concentrations in the wet tissues. The data represent two independent experiments. *P , 0.05 (one-way analysis of variance).
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Interestingly, significant Ag content in the liver and 
kidney was detected in AgNP/NSP-treated chicks. The high 
Ag content in the liver and kidney may be caused by the 
partial dissolution of Ag ions from the Ag nanomaterials 
under acidic or basic environment, such as in the stomach 
or intestine, respectively. The released Ag ions may subse-
quently be passively diffused from the GI tract into the blood 
and accumulate in the liver and kidney. In addition, although 
the geometric shape of NSP and its derivatives may hinder the 
direct diffusion of the nanomaterials from the intestinal lumen 
into the blood, AgNP/NSP may be engulfed by enterocytes 
or M cells residing in the lumen.31 Through endocytosis, 
intracellular transport, and excretion, the nanomaterials may 
be transported through the enterocytes to the blood and be 
systemically delivered to other organs.
Another interesting finding was that the Ag in the liver 
and kidney of AgNP/NSP-treated chicks was comparable 
with that in the intestines of AgNP-treated chicks. Previous 
studies demonstrated that the distribution of Ag in adult rats 
following AgNP feeding for 28 consecutive days resulted in 
ten-fold higher Ag accumulation in the intestine than in the 
liver and kidney.27 These explanations include a variable GI 
absorption rate, metabolism, and the excretion of the nanoma-
terial in different species and at different ages. For example, a 
dramatic difference was documented between the distribution 
of Ag granules in the kidney of rats and rabbits.32 The deposi-
tion of ingested Ag in rat kidney also exhibited a varied Ag 
density and Ag granule distribution between young and adult 
animals.33 Abundant Ag-binding substances in the liver and 
kidney or slow excretion of Ag through the bile duct or urine in 
chicks may also contribute to the high Ag deposition observed 
in both organs. Explaining this discrepancy requires a long-
term toxicity evaluation of AgNP/NSP in rats and comparing 
the safety and organ distribution of the nanohybrid with that of 
pure AgNPs. In addition, further experiments are required to 
determine which form of Ag, such as Ag ions, intact AgNPs, 
or AgNP/NSPs, is absorbed and accumulated in the liver and 
kidney in the nanohybrid-treated animals.
The efficacy of the tested nanomaterials on Salmonella 
infection and the postulated hypotheses are summarized 
in Figure 8. In addition, observation and quantitative Ag 
analyses indicated that orally administrated AgNP/NSP 
was mainly excreted from the body through the feces. The 
absorbed Ag from the nanohybrids was accumulated in the 
intestine, liver, and kidney, similar to the reported distribution 
of AgNPs fed to mice.27,34–36 The comparative tests between 
AgNP/NSP and AgNPs demonstrated that the Ag deposition 
from AgNP/NSP in the internal organs was less than that 
observed from conventional AgNPs.
Conclusion
Our experiments demonstrated that NSP and AgNP/NSP, 
but not AgNPs alone, were potential antimicrobial agents 
for controlling enteric bacterial infection. In contrast to the 
considerable Ag deposits in the GI tract upon application of 
AgNPs, the Ag accumulation in digestive tissues from AgNP/
NSP was significantly decreased, showing improved safety 
over conventional AgNPs in animals.
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Figure S1 The antimicrobial effect of the silver nanoparticle (AgNPs). Approximately 1 × 103 Salmonella pullorum and Escherichia coli, synchronized at the log phase of the 
growth curve, were spread on Luria-Bertani agars where AgNPs or AgNP/nanoscale silicate platelet (NSP) were mixed with at the indicated concentrations.
Note: The numbers of colonies were counted after overnight incubation at 37°C.
Table S1 Histopathological findings in the nanomaterial-fed chicks
Organs/degreea Chicks
Control AgNP/NSP NSP AgNPs
5 days  
old
10 days  
old
5 days  
old
10 days  
old
5 days  
old
10 days  
old
5 days  
old
10 days 
old
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4
Gizzard – – – – – – – – – – – – – – – –
Proventriculus – – – – – – – – – – – – – – – –
Small intestine – – – – – – – – – – – – – – – –
Large intestine – – – – – – – – – – – – – – – –
Lung – – – – – – – – – – – – – – – –
Heart – – – – – – – – – – – – – – – –
Liver – – – – – – – – – – – – – – – –
Kidney – – – – – – – – – – – – – – – –
Notes: –No significant lesion.  aDegree of lesions was graded from 1 to 4 depending on severity: 1 = minimal (,1%); 2: slight (1%–25%); 3 = moderate (26%–50%);   
4 = moderate/severe (51%–75%); 5 = severe/high (76%–100%).
Abbreviations: AgNP, silver nanoparticle; NSP, nanoscale silicate platelet.
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